4th Quarter - Report

STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832

LobbyistCovered position, as disclosed
JAMES DERDERIAN Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
VALERIE HENRY Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
AISLING MCDONOUGH Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
JOSEPH RACHINSKY —
BRYAN WILLIAM WELLS Policy Advisor, Senator Pat Roberts

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3832 (119th), H.R. 7142 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.